It was great to chat to the BBC Science Focus “Instant Genius” podcast about dementia, familial Alzheimer’s disease, stem cell models & how the field is moving towards better diagnosis and new therapies. Spotify link below but listen wherever you get your podcasts! open.spotify.com/episode/1frL...

On the frontlines of our fight against dementia

Instant Genius · Episode

open.spotify.com

🎉 Congratulations to the Faculty of Brain Sciences researchers who have received NIHR funding for quantum health technology projects! @uclqsion.bsky.social @ucleye.bsky.social www.ucl.ac.uk/brain-scienc...

Faculty of Brain Sciences researchers receive NIHR funding for quantum health technology projects

The NIHR has awarded four Faculty of Brain Sciences projects funding to support the early-stage development of quantum technologies.

ucl.ac.uk

"The help and knowledge in the toolkit has given me confidence to manage" A toolkit is now publicly available for people with Parkinson’s and their carers, providing a trusted source of information that boosts confidence in managing #Parkinson’s day-to-day. www.ucl.ac.uk/population-h...

“UCL Live Well With Parkinson's” Toolkit launched

A self-management toolkit is now publicly available for people with Parkinson’s and their carers.

ucl.ac.uk

...Insight articles on the 75th anniversary of @uclqsion.bsky.social and the relevance of El Niño for neurologists, and more! www.thelancet.com/journals/lan...

Congratulations to IoN dept of Neuromuscular Diseases colleagues on their very well deserved promotions: • Gita Ramdharry promotion to Professor of Physiotherapy • Dipa Jayaseelan promotion to Associate Professor • Roope Mannikko promotion to Principal Research Fellow www.ucl.ac.uk/brain-scienc...

Senior Academic, Research and Teaching Promotions 2025-26

Huge congratulations to the UCL Queen Square Institute of Neurology staff who have been awarded a promotion in this year's promotions round.

ucl.ac.uk

*Save the date* 🗓️ 20th Annual Neuromuscular Translational Research Conference will take place Tuesday 20th and Wednesday 21st April 2027, at the UCL Institute of Child Health in London. More info to follow in coming months.

A pioneering experimental treatment for motor neurone disease (MND), developed by UCL spinout Trace Neuroscience, will be trialled in humans as part of a new international clinical programme - www.ucl.ac.uk/news/2026/ju...

Novel treatment for motor neurone disease to be trialled in humans

A pioneering experimental treatment for motor neurone disease (MND), developed by UCL spinout Trace Neuroscience, will be trialled in humans as part of a new international clinical programme.

ucl.ac.uk

UCL and MANX MSA Trust Strengthen Partnership with New Research Programme into Biomarker Discovery. A new research programme at UCL Queen Square Institute of Neurology will investigate novel biomarkers for Multiple System Atrophy (MSA) - www.ucl.ac.uk/brain-scienc...

UCL and MANX MSA Trust Strengthen Partnership with New Research Programme into Biomarker Discovery

A new research programme at UCL Queen Square Institute of Neurology will investigate novel biomarkers for Multiple System Atrophy (MSA)

ucl.ac.uk

I am still a bit stunned but also delighted to share that from 1st October 2026 I will be a Professor of Physiotherapy at UCL. 1/3 Senior Academic, Research and Teaching Promotions 2025-26 | UCL Faculty of Brain Sciences share.google/E48HGRYdDCJ8...

Senior Academic, Research and Teaching Promotions 2025-26

Huge congratulations to the UCL Queen Square Institute of Neurology staff who have been awarded a promotion in this year's promotions round.

share.google

A pioneering experimental treatment for motor neurone disease (MND), developed by UCL spinout Trace Neuroscience, will be trialled in humans as part of a new international clinical programme. www.ucl.ac.uk/news/2026/ju... @uclqsion.bsky.social

Novel treatment for motor neurone disease to be trialled in humans

A pioneering experimental treatment for motor neurone disease (MND), developed by UCL spinout Trace Neuroscience, will be trialled in humans as part of a new international clinical programme.

ucl.ac.uk

A new £3.8m @wellcometrust.bsky.social Discovery Award will support @uclqsion.bsky.social , @kingsioppn.bsky.social and @ukdri.ac.uk research into cellular mechanisms that protect against toxic protein build-up. www.ucl.ac.uk/brain-scienc...

£3.8m awarded to study protective mechanisms against neuron damage and ageing

A £3.8 million Wellcome Discovery Award will support research into how neurons protect themselves from toxic protein build-up during ageing.

ucl.ac.uk

How might neurons protect themselves from toxic protein build-up?🧠 @ulelab.bsky.social & @mbourdenx.bsky.social have been awarded £3.8m by @wellcometrust.bsky.social to study role of interstasis in protecting neurons ukdri.ac.uk/news-and-eve... @kingsioppn.bsky.social @uclbrainscience.bsky.social

Two UK DRI Group Leaders awarded major Wellcome funding to study protective mechanisms against neuron damage and ageing

A new study, co-led by researchers at the UK DRI at King’s and the UK DRI at UCL will investigate how neurons can protect themselves from toxic protein accumulation, with implications for neurodegener...

ukdri.ac.uk

How can the brain 🧠 promote healthy ageing? @ulelab.bsky.social at King's and Dr Mathieu Bourdenx (UCL) have been awarded £3.8m by @wellcometrust.bsky.social to study role of interstasis in protecting neurons. www.kcl.ac.uk/news/3.8m-aw... #AgingResearch @ukdri.ac.uk @uclbrainscience.bsky.social

£3.8m awarded to study protective mechanisms against neuron damage and ageing | King's College London

A new study, co-led by neuroscientists at King’s College London, University College London and the UK Dementia Research Institute (UK DRI), will investigate how neurons can protect themselves from toxic protein accumulation, with implications for neurodegenerative diseases and ageing.

kcl.ac.uk

MPs, experts & families affected by Friedreich's Ataxia have called on the government to enable interim access to Omaveloxolone (Omav) - the first licensed treatment for the rare neurodegenerative disease & the only one shown to slow its progression. www.uclhospitals.brc.nihr.ac.uk/news/calls-a...

Calls for action on early access to Friedreich's Ataxia treatment

MPs, experts and families affected by the rare neurodegenerative disease Friedreich's Ataxia (FA) called on the government this month to enable interim access to a drug for which UCLH and UCL led the ...

uclhospitals.brc.nihr.ac.uk

Here is an interesting new JPNS paper from Brazil and UCL collaborators, describing two instances of late-onset Tay-Sachs disease. onlinelibrary.wiley.com/doi/10.1111/...

<em>Journal of the Peripheral Nervous System</em> | PNS Neuroscience Journal | Wiley Online Library

Background Late-onset Tay–Sachs disease (LOTS) is a rare lysosomal disorder that contrasts with the classical infantile form by presenting with milder and heterogeneous neurological manifestations, ...

onlinelibrary.wiley.com

BrightFocus Foundation's National Glaucoma Research has just awarded 16 new research grants totaling $2.3 million to support scientists dedicated to preventing, treating, and curing glaucoma. Meet this exceptional group of vision science innovators moving us closer to a cure: https://bit.ly/3TkVC2V

A new treatment for early Alzheimer’s disease has shown encouraging results with UCLH consultant, Professor Cath Mummery, reporting both slower cognitive decline and significant reductions in the tau protein in the brains of participants.

Alzheimer's trial drug shows promise for slowing cognitive decline

A new treatment for early Alzheimer’s disease has shown encouraging results with UCLH consultant, Prof Cath Mummery, reporting both slower cognitive decline and significant reductions in the tau prote...

uclhospitals.brc.nihr.ac.uk

UCL Technical Showcase 2026 - UCL200 Special Edition, 8 - 9 July 2026. Kully Sunner & Charlotte Spicer promoting ChemInventory, a joint initiative with IoN-DRI Project & School of Pharmacy. For further information contact Kully Sunner (k.sunner@ucl.ac.uk) and Duncan Browne (duncan.browne@ucl.ac.uk)

Our long service event brought together colleagues who have worked at UCL for 25 years or more to celebrate their remarkable contributions and commemorate UCL’s bicentenary - www.ucl.ac.uk/news/2026/ju...

A research team from @uclqsion.bsky.social has established how the NHS could double the number of patients it diagnoses with dementia by using faster brain scans. observer.co.uk/news/nationa...

The brain scan that could help fight Alzheimer’s

Scientists have shown how the NHS could double the number of patients it diagnoses with dementia, which could help them to get vital treatment

observer.co.uk

New research suggests that memory actively shapes how we see and interpret the world around us, and how we make predictions about the future. @uclqsion.bsky.social @peterkok.bsky.social www.ucl.ac.uk/brain-scienc...

How the brain predicts the future

New research suggests that memory actively shapes how we see and interpret the world around us, and how we make predictions about the future.

ucl.ac.uk

If attending #AAIC #AAIC26 @alzassociation.bsky.social this week, do come and talk to us about our research @ukdri.ac.uk @alzresearchuk.bsky.social @alzheimerssoc.bsky.social @qs-neurogenetics.bsky.social @uclqsion.bsky.social

The hippocampus sits at the interface of perception & memory, allowing us to link past, present, & future through its role in generating predictions. Excited to share this theme issue in @royalsociety.org's Philosophical Transactions B, co-edited with @barense.bsky.social & @mariamaly.bsky.social

Volume 381 Issue 1954 | Philosophical Transactions of the Royal Society B | The Royal Society

Influential themed journal issues across the life sciences.

royalsocietypublishing.org

Here is the press release following the Parliament event Prof Giunti attended to call for action to: • Provide interim access pathway for Omaveloxolone • Reform the drug appraisal system for reimbursement on the NHS for #rarediseases @uclqsion.bsky.social www.ucl.ac.uk/brain-scienc...

Professor Paola Giunti backs call for action on early access to Friedreich's Ataxia treatment

On 1 July 2026, Professor Giunti joined Ataxia UK, MPs, experts and families affected by Friedreich's Ataxia at a Parliamentary event on urgent government action on interim access to Omaveloxolone

ucl.ac.uk

Can’t make it to #AAIC26? Join us virtually for #AAIC4All on July 16! Choose a tailored track for either community members or clinicians & health care providers and hear about what’s next in dementia science. Register now: alz.org/aaic-for-all.

Prof Giunti attended a Parliamentary event with Ataxia UK and families affected by #FriedreichsAtaxia to call for urgent government action for interim access pathway for omaveloxolone (Omav) and reform the #medicines appraisal system for #rarediseases in the UK. #AccessOmavNow @uclqsion.bsky.social

The very fit and healthy team here at UCL Queen Square Institute of Neurology are running 10K for the National Brain Appeal this weekend, under a hot sun! Runners include our Director Professor Mike Hanna. Please consider donating to this excellent charity! www.justgiving.com/page/the-nat...

We are running the Saucony London 10K 2026!

Help The National Brain Appeal Page raise money to support The National Brain Appeal

justgiving.com

#BrainMeeting 🧠 Alert! 🎺 This Friday, July 10th, the Brain Meeting speaker will be Chetan Gohil giving a talk entitled "Leveraging Large-Scale Datasets for Dynamic Brain Network Modelling". In person or online. Read more: www.in.fil.ion.ucl.ac.uk/events

Understand what’s next in Alzheimer’s and dementia research and learn ways to join the cause at #AAICForAll! Attend this no-cost virtual event on July 16. Register now: alz.org/aaic-for-all.

Happy 75th birthday to UCL Queen Square Institute of Neurology 🎉 Yesterday was a wonderful celebration of the pioneering work that has been done to understand and treat neurological diseases that has impacted people all over the world. 1/3